Eiger BioPharmaceuticals, Inc. Recorded Big Gain

Thu, Mar 17, 2022 at 05:30 PM
Eiger BioPharmaceuticals, Inc. Recorded Big Gain

Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ) soared at $7.98, representing a gain of 40.2%. On Tue, Mar 15, 2022, EIGR:NASDAQ hit a New 2-Week High of $5.45. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 09:47 AM in the 'BIOTECH' category. From Tue, Mar 01, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days

About Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ)

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.